Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Dare Bioscience (DARE) EBIT Margin (2022 - 2025)

Historic EBIT Margin for Dare Bioscience (DARE) over the last 4 years, with Q3 2025 value amounting to 162340.76%.

  • Dare Bioscience's EBIT Margin fell 1511120800.0% to 162340.76% in Q3 2025 from the same period last year, while for Sep 2025 it was 30578.09%, marking a year-over-year increase of 318131200.0%. This contributed to the annual value of 239692.2% for FY2024, which is 2385903100.0% down from last year.
  • As of Q3 2025, Dare Bioscience's EBIT Margin stood at 162340.76%, which was down 1511120800.0% from 18079.54% recorded in Q2 2025.
  • Over the past 5 years, Dare Bioscience's EBIT Margin peaked at 18079.54% during Q2 2025, and registered a low of 162340.76% during Q3 2025.
  • Moreover, its 4-year median value for EBIT Margin was 6034.16% (2023), whereas its average is 26370.57%.
  • Examining YoY changes over the last 5 years, Dare Bioscience's EBIT Margin showed a top increase of 508786600bps in 2025 and a maximum decrease of -1511120800bps in 2025.
  • Dare Bioscience's EBIT Margin (Quarter) stood at 3.84% in 2022, then tumbled by -7543bps to 286.05% in 2023, then soared by 3060bps to 8465.75% in 2024, then crashed by -2018bps to 162340.76% in 2025.
  • Its EBIT Margin stands at 162340.76% for Q3 2025, versus 18079.54% for Q2 2025 and 18016.75% for Q1 2025.